Guardant Health to present data at San Antonio Breast Cancer

Spotlight sessions highlight role of Guardant blood tests in tissue-free detection of minimal residual disease and predictive impact of ctDNA genomic profiling



MRD study found ctDNA detection...

Related Keywords

San Antonio , Texas , United States , Germany , German , , Nasdaq , Guardant Health , Exchange Commission , Facebook , Guardant Health Inc , Linkedin , Guardant Health Forward , San Antonio Breast Cancer Symposium , Craig Eagle , Guardant Reveal , Triple Negative Breast Cancer , Informative Outcomes , Liquid Biopsy , Real World Population , Advanced Breast Cancer , Financial Condition , Annual Report , Markets ,